Searchable abstracts of presentations at key conferences in endocrinology
Previous issue | Volume 99 | ECE2024

26th European Congress of Endocrinology

Stockholm, Sweden
11 May 2024 - 14 May 2024

Card image cap
We are pleased to announce that ECE 2024 will be held in Stockholm, Sweden from 11-14 May 2024. We will, once again, be offering the hybrid format next year so you can join us in person in Sweden or remotely with ECE@Home.

Rapid Communications

Rapid Communications 9: Pituitary and Neuroendocrinology | Part II

ea0099rc9.1 | Rapid Communications 9: Pituitary and Neuroendocrinology | Part II | ECE2024

Assessment of cardiovascular risk and coronary calcium deposits in women with hypopituitarism

Salhi Salma , Oueslati Ibtissem , Boukriba Seif , Talbi Emna , Yazidi Meriem , Feki Moncef , Mizouni Habiba , Chihaoui Melika

Introduction: Cardiovascular diseases are frequent in patients with hypopituitarism receiving conventional hormone replacement therapy. They represent the main cause of premature death in this population. Emerging evidence smggests that beyond traditional risk factors, evaluating coronary calcium score (CCS) and inflammatory markers such as high-sensitivity C-reactive protein (hs-CRP) provides valuable insights into cardiovascular health in this population. The aims of the pre...

ea0099rc9.2 | Rapid Communications 9: Pituitary and Neuroendocrinology | Part II | ECE2024

Elevated prolactin: Do not over investigate, cannulate!

Hawkins Anna , Enriquez Nancy , Tanday Raj , Shah Usman , Chan Carmela , Casey Edel , Nikookam Khash

Aim: Role of Endocrine Specialist Nurse (ESN) in performing cannulated prolactin and subsequent impact on outpatient clinic activities.Introduction: Hyperprolactinemia is a common condition in endocrine clinical practice. It may occur in any sex, at any age and its prevalence and incidence depend on study population. The most common physiological causes of elevated prolactin are stress, lactation, pregnancy and exercise. Non-physiological causes include ...

ea0099rc9.3 | Rapid Communications 9: Pituitary and Neuroendocrinology | Part II | ECE2024

Identifying potential small molecule “metabolites” as biomarkers for growth hormone deficiency (GHD): Insights from a novel mouse model

Al-Samerria Sarmed , Xu Huiting , Phelan Joseph , Diaz Rubio Maria Elena , Yamada Sayaka , Negron Ariel , Wondisford Fredric , Radovick Sally

Growth hormone deficiency (GHD) diagnosis poses a significant challenge since no test definitively diagnoses GHD. The current diagnostic approach for GHD relies on a determination of auxologic parameters followed by determining Growth Hormone (GH) levels and Insulin-like Growth Factor-I (IGF-I) in serum. However, clinical assessment and interpretation of GH and IGF-1 levels lack sensitivity. Further provocative studies of GH secretion do not have a precise cutoff level that di...

ea0099rc9.4 | Rapid Communications 9: Pituitary and Neuroendocrinology | Part II | ECE2024

The novel SST3 agonist ITF2984 exerts antimitotic and proapoptotic effects in human non-functioning pituitary neuroendocrine tumor (NF-PitNET) cells

Di Muro Genesio , Catalano Rosa , Treppiedi Donatella , Maria Barbieri Anna , Mangili Federica , Marra Giusy , Di Bari Sonia , Esposito Emanuela , Nozza Emma , Lania Andrea , Locatelli Marco , Modena Daniela , Steinkuhler Christian , Peverelli Erika , Mantovani Giovanna

Non-functioning pituitary neuroendocrine tumors (NF-PitNETs) are still orphan of medical therapy. The drmgs approved for the other types of PitNETs, e.g. somatostatin analogues (SSA) with high affinity for somatostatin receptors (SSTs) type 2 (SST2) and 5 (SST5) are poorly efficacious in NF-PitNETs. Among SSTs, NF-PitNETs express high levels of SST3, a receptor that can mediate antiproliferative and apoptotic signaling. ITF2984 is a pan-SST ligand with high affinity for SST3, ...

ea0099rc9.5 | Rapid Communications 9: Pituitary and Neuroendocrinology | Part II | ECE2024

Pregnancy and acromegaly: Clinical outcomes of retrospectively analysed data from the German Acromegaly Registry

Tonjes Anke , Wurfel Marleen , Quinkler Marcus , Knappe Ulrich , Honegger Jurgen , Krause.Joppig Nina , Bacher Konrad , Schopohl Jochen , Stormann Sylvere , Meyhofer Sebastian

Context: Acromegaly is a rare disease caused by excessive growth hormone (GH) secretion, mostly induced by pituitary adenomas. The care of pregnant women with acromegaly is challenging, in part due to existing clinical data being limited and not entirely consistent with regard to potential risks for mother and child.Objective: To retrospectively examine data on pregnancy and maternal as well as neonatal outcomes in patients with acromegaly.<p class="...

ea0099rc9.6 | Rapid Communications 9: Pituitary and Neuroendocrinology | Part II | ECE2024

Prevalence and determinants of microvascular and macrovascular complications of diabetes in acromegaly patients: A prospective case-control cross-sectional study

Pirchio Rosa , Auriemma Renata Simona , Scairati Roberta , Tropiano Antonella , De Simone Ivan , Vergura Alice , Del Vecchio Guendalina , Pivonello Claudia , Pivonello Rosario , Colao Annamaria

Context: Although diabetes mellitus is a major complication in patients with acromegaly, prevalence and determinants of microvascular and macrovascular complications of diabetes remains unexplored in this population.Aim: To investigate prevalence and determinants of microvascular and macrovascular complications in acromegaly patients with diabetes and to compare them with a group of diabetic patients without acromegaly.Methods: Pro...

ea0099rc9.7 | Rapid Communications 9: Pituitary and Neuroendocrinology | Part II | ECE2024

Pituitary apoplexy: A retrospective canadian single center cohort study

Parker Ellen , Ali Imran S. , Hebb Andrea , Kureshi Nelofar , Clarke David

Introduction: Pituitary apoplexy is a rare clinical syndrome that often involves headache, visual deficits, and endocrine dysfunction resulting from infarction or hemorrhage of a pituitary tumor. Due in part to the rare nature of this condition, there are few large studies on pituitary apoplexy described in the literature. Here, we present a large single center retrospective cohort study of patients with pituitary apoplexy managed surgically or conservatively.<p class="abs...